ADMA BIOLOGICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for ADMA BIOLOGICS, INC. (ADMA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ADMA insiders buying or selling?
In the last 12 months, ADMA BIOLOGICS, INC. insiders reported 4 open-market purchases ($468.3K) and 6 sales ($1.9M) — net selling of $1.4M. Since May 2018, Trabud has recorded 78 Form 4 filings for ADMA: 40 buys ($36.5M) and 38 sells ($77.6M).
Source: SEC EDGAR Form 4
Key Statistics (May 2018 – May 28, 2026)
Total Form 4 filings
78
SEC EDGAR
Insider filers
15
Insider buys (40)
$36.5M
Insider sells (38)
$77.6M
Insider sentiment
Net sellingNet insider flow of $41.1M in net selling since May 2018, and $1.4M in net selling over the last 12 months.
Recent ADMA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | Grossman Jerrold B | Director | Purchase | 6.4K | $7.91 | $50.6K | SEC ↗ |
| May 14, 2026 | Grossman Jerrold B | Director | Purchase | 12.5K | $8.01 | $100.1K | SEC ↗ |
| May 12, 2026 | Grossman Jerrold B | Director | Purchase | 12.5K | $8.01 | $100.1K | SEC ↗ |
| Mar 18, 2026 | Adam S Grossman | President and CEO | Sale | 21.0K | $15.16 | $318.4K | SEC ↗ |
| Mar 11, 2026 | Kaitlin M. Kestenberg-Messina | COO and SVP, Compliance | Sale | 10.1K | $15.63 | $157.8K | SEC ↗ |
| Mar 9, 2026 | ELMS STEVE | Director | Purchase | 14.0K | $15.53 | $217.4K | SEC ↗ |
| Feb 18, 2026 | Adam S Grossman | President and CEO | Sale | 21.0K | $16.08 | $337.7K | SEC ↗ |
| Dec 17, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $19.79 | $415.6K | SEC ↗ |
| Nov 22, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $16.00 | $336.0K | SEC ↗ |
| Oct 25, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $16.00 | $336.0K | SEC ↗ |
| Sep 17, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $16.13 | $338.7K | SEC ↗ |
| Aug 16, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $16.88 | $354.5K | SEC ↗ |
| Jul 17, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $18.66 | $391.9K | SEC ↗ |
| Jun 19, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $20.81 | $437.0K | SEC ↗ |
| Jun 17, 2025 | ELMS STEVE | Director | Sale | 425.6K | $20.74 | $8.8M | SEC ↗ |
| Jun 12, 2025 | Lawrence P. Guiheen | Director | Sale | 20.0K | $20.96 | $419.2K | SEC ↗ |
| Jun 11, 2025 | Grossman Jerrold B | Director | Sale | 10.0K | $21.31 | $213.1K | SEC ↗ |
| May 24, 2025 | Lawrence P. Guiheen | Director | Sale | 9.0K | $20.29 | $182.6K | SEC ↗ |
| May 17, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $19.45 | $408.4K | SEC ↗ |
| Apr 17, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $21.46 | $450.7K | SEC ↗ |
| Mar 22, 2025 | Adam S Grossman | President and CEO | Sale | 21.0K | $18.92 | $397.3K | SEC ↗ |
| Nov 23, 2024 | Brad L. Tade | CFO and Treasurer | Sale | 15.0K | $21.15 | $317.3K | SEC ↗ |
| Nov 23, 2024 | Adam S Grossman | President and CEO | Sale | 49.0K | $21.10 | $1.0M | SEC ↗ |
| Sep 12, 2024 | Lawrence P. Guiheen | Director | Sale | 9.0K | $18.47 | $166.2K | SEC ↗ |
| Aug 31, 2024 | Kaitlin M. Kestenberg-Messina | COO and SVP, Compliance | Sale | 24.1K | $16.90 | $408.1K | SEC ↗ |
Showing the 25 most recent of 78 Form 4 filings for ADMA BIOLOGICS, INC..
Most active ADMA insiders
- Adam S Grossman24 filings
- Grossman Jerrold B13 filings
- Brian Lenz7 filings
- Joseph Edelman7 filings
- Lawrence P. Guiheen6 filings
Ask anything about ADMA insider activity
Use Trabud's AI agent to query ADMA BIOLOGICS, INC.'s Form 4 history in plain English — "Show me ADMA CEO purchases this year" or compare it against any other ticker.
Open the AI agentADMA insider trading FAQ
Are ADMA BIOLOGICS, INC. insiders buying or selling?
In the last 12 months, ADMA BIOLOGICS, INC. insiders reported 4 open-market purchases ($468.3K) and 6 sales ($1.9M) — net selling of $1.4M. Since May 2018, Trabud has recorded 78 Form 4 filings for ADMA: 40 buys ($36.5M) and 38 sells ($77.6M). Over the full record that is net selling of $41.1M.
How many insiders trade ADMA stock?
15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ADMA BIOLOGICS, INC.. The most recent filing was accepted on May 28, 2026.
Where does Trabud get ADMA insider trading data?
All ADMA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.